A Study of RPT1G After Single and Multiple Doses in Healthy Adult Participants

Phase 1 Completed 56 enrolled Remedy Plan, Inc. Remedy Plan Australia Pty. Ltd. · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

This is a first-in-human (FIH), randomized, double-blind, placebo-controlled, single and multiple dose study with staggered dose escalations in healthy participants.

Timeline

Start: 2024-11-18
Primary completion: 2025-05-14
Completion: 2025-05-14

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	RPT1G	Unknown	—	Oral

Indications

No indication recorded.